26876244|t|Brain fluorodeoxyglucose (FDG) PET in dementia.
26876244|a|The purpose of this article is to present a selective and concise summary of fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG PET is used to visualize a downstream topographical marker that indicates the distribution of neural injury or synaptic dysfunction, and can identify distinct phenotypes of dementia due to Alzheimer's disease (AD), Lewy bodies, and frontotemporal lobar degeneration. AD dementia shows hypometabolism in the parietotemporal association area, posterior cingulate, and precuneus. Hypometabolism in the inferior parietal lobe and posterior cingulate/precuneus is a predictor of cognitive decline from mild cognitive impairment (MCI) to AD dementia. FDG PET may also predict conversion of cognitively normal individuals to those with MCI. Age-related hypometabolism is observed mainly in the anterior cingulate and anterior temporal lobe, along with regional atrophy. Voxel-based statistical analyses, such as statistical parametric mapping or three-dimensional stereotactic surface projection, improve the diagnostic performance of imaging of dementias. The potential of FDG PET in future clinical and methodological studies should be exploited further.
26876244	6	24	fluorodeoxyglucose	Chemical	MESH:D019788
26876244	26	29	FDG	Chemical	MESH:D019788
26876244	38	46	dementia	Disease	MESH:D003704
26876244	125	143	fluorodeoxyglucose	Chemical	MESH:D019788
26876244	145	148	FDG	Chemical	MESH:D019788
26876244	188	196	dementia	Disease	MESH:D003704
26876244	206	209	FDG	Chemical	MESH:D019788
26876244	304	317	neural injury	Disease	MESH:D014947
26876244	321	341	synaptic dysfunction	Disease	MESH:C536122
26876244	383	391	dementia	Disease	MESH:D003704
26876244	399	418	Alzheimer's disease	Disease	MESH:D000544
26876244	420	422	AD	Disease	MESH:D000544
26876244	425	436	Lewy bodies	Disease	MESH:D020961
26876244	442	475	frontotemporal lobar degeneration	Disease	MESH:D057174
26876244	477	488	AD dementia	Disease	MESH:D000544
26876244	495	509	hypometabolism	Disease	
26876244	587	601	Hypometabolism	Disease	
26876244	684	701	cognitive decline	Disease	MESH:D003072
26876244	712	732	cognitive impairment	Disease	MESH:D003072
26876244	734	737	MCI	Disease	MESH:D060825
26876244	742	753	AD dementia	Disease	MESH:D000544
26876244	755	758	FDG	Chemical	MESH:D019788
26876244	839	842	MCI	Disease	MESH:D060825
26876244	856	870	hypometabolism	Disease	
26876244	964	971	atrophy	Disease	MESH:D001284
26876244	1149	1158	dementias	Disease	MESH:D003704
26876244	1177	1180	FDG	Chemical	MESH:D019788
26876244	Association	MESH:D019788	MESH:C536122
26876244	Association	MESH:D019788	MESH:D000544
26876244	Association	MESH:D019788	MESH:D003704
26876244	Association	MESH:D019788	MESH:D014947
26876244	Association	MESH:D019788	MESH:D057174
26876244	Association	MESH:D019788	MESH:D060825
26876244	Association	MESH:D019788	MESH:D020961

